| Unique ID issued by UMIN | UMIN000059216 |
|---|---|
| Receipt number | R000067729 |
| Scientific Title | Effects of Maca Intake on Male Fatigue Resistance and Quality of Life |
| Date of disclosure of the study information | 2025/11/30 |
| Last modified on | 2025/09/27 16:14:16 |
Effects of Maca Intake on Male Fatigue Resistance and Quality of Life
Effects of Maca Intake on Male Fatigue Resistance and Quality of Life
Effects of Maca Intake on Male Fatigue Resistance and Quality of Life
Effects of Maca Intake on Male Fatigue Resistance and Quality of Life
| Japan |
Healthy adult males
| Adult |
Others
NO
To investigate whether maca intake improves fatigue and quality of life in men.
Safety,Efficacy
Confirmatory
Fatigue-related VAS, Vigar-Activity (VA) using POMS2
Salivary testosterone, POMS2 Quality of Life Assessment (excluding Viger-Activity), AMS Score, IIEF5 Score
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
YES
No need to know
2
Treatment
| Food |
Foods containing maca-derived ingredients
Placebo food
| 20 | years-old | <= |
| 60 | years-old | >= |
Male
(1) Healthy adult males
(2) Individuals with a BMI below 30 kg/m2
(1) Individuals currently receiving medication for any medical condition
(2) Individuals consuming foods or health supplements containing the active ingredient of this test food
(3) Individuals with functional erectile dysfunction
(4) Individuals with serious diseases or psychiatric disorders affecting glucose metabolism, lipid metabolism, liver function, kidney function, heart, circulatory system, respiratory system, endocrine system, immune system, or nervous system; and individuals with a history of such conditions
(5) Individuals who have shown abnormal clinical laboratory values in recent health checkups and are deemed unsuitable for trial participation
(6) Individuals with currently treated diseases or a history of serious diseases requiring medication
(7) Individuals at risk of developing allergies related to the trial
(8) Individuals deemed unsuitable as subjects based on responses to the lifestyle questionnaire
(9) Individuals participating in other clinical studies at the start of this trial
(10) Individuals deemed unsuitable for trial participation by the Principal Investigator (or Study Director)
50
| 1st name | Ryuji |
| Middle name | |
| Last name | Takeda |
Kansai University of Welfare Sciences
Department of Nutritional Sciences for Welll-being, Faculty of Health Science for Welfare
582-0026
Asahigaoka 3-11-1, Kashiwara, Osaka
0729780088
rtakeda@tamateyama.ac.jp
| 1st name | Shigefumi |
| Middle name | |
| Last name | Nibun |
EAS inc.
Clinical Trial Session
239-0028
Susaki-Cho1-10-2F, Kanazawa-ku, Yokohama city, Kanagawa
045-374-3392
info@eas-ct.jp
Sukoyaka-Kobo Inc.
Sukoyaka-Kobo Inc.
Profit organization
KOBUNA ORTHOPEDIC SURGERY
311-2, Gokan-machi, Maebashi, Gunma
027-261-7600
sagawa@mc-connect.co.jp
NO
| 2025 | Year | 11 | Month | 30 | Day |
Unpublished
Preinitiation
| 2024 | Year | 08 | Month | 26 | Day |
| 2025 | Year | 10 | Month | 05 | Day |
| 2026 | Year | 03 | Month | 31 | Day |
| 2025 | Year | 09 | Month | 27 | Day |
| 2025 | Year | 09 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000067729